Dr David Virshup is the inaugural director of the Cancer and Stem Cell
Biology program at the Duke-NUS medical school in Singapore and a Professor of
Pediatrics at Duke University.
David has gained
international recognition for his pioneering research at the intersection of
developmental pathways and cancer genetics. A renowned pediatrician and
researcher specializing in upstream regulators of the Wnt signaling pathway,
his work has advanced our biological understanding of cancer, stem cells and
developmental programs and importantly led to a new Wnt inhibitor currently in
clinical trials.
His work is topical
and should appeal to a broad audience interested in cancer, cell signaling,
regeneration and development, and therapeutic development to name a few.
No comments:
Post a Comment